• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二氢嘧啶酶缺乏症,一种进行性神经疾病?

Dihydropyrimidinase deficiency, a progressive neurological disorder?

作者信息

Putman C W, Rotteveel J J, Wevers R A, van Gennip A H, Bakkeren J A, De Abreu R A

机构信息

Department of Paediatric Neurology, University Hospital Nijmegen, The Netherlands.

出版信息

Neuropediatrics. 1997 Apr;28(2):106-10. doi: 10.1055/s-2007-973681.

DOI:10.1055/s-2007-973681
PMID:9208410
Abstract

A case of a child presenting with congenital abnormalities at birth is reported. The early development remained severely retarded and acquired skills minimally. The head circumference centile decreased. Magnetic resonance imaging showed progressive neuronal atrophy and secondary delay in myelination. Dihydropyrimidine concentrations in body fluids were quantitated by NMR spectroscopy. Enzymatic assay in the liver biopsy revealed total deficiency of dihydropyrimidinase (DHP) (5,6-dihydropyrimidine amidohydrolase; EC 3.5.2.2). As such, the patient is the first with enzymatically proven DHP deficiency. Thus far dihydropyrimidinuria has been reported in three other patients with a variety of neurological abnormalities. A relation of the enzyme deficiency with the neurodegenerative clinical course in our patient is suggested.

摘要

本文报告了一例出生时即患有先天性异常的儿童病例。其早期发育严重滞后,获得的技能极少。头围百分位下降。磁共振成像显示神经元进行性萎缩以及髓鞘形成继发性延迟。通过核磁共振波谱法定量测定了体液中的二氢嘧啶浓度。肝活检的酶学分析显示二氢嘧啶酶(DHP)(5,6 - 二氢嘧啶酰胺水解酶;EC 3.5.2.2)完全缺乏。因此,该患者是首例经酶学证实的二氢嘧啶酶缺乏症患者。迄今为止,另外三名患有各种神经异常的患者也报告了二氢嘧啶尿症。提示该酶缺乏与我们患者的神经退行性临床病程有关。

相似文献

1
Dihydropyrimidinase deficiency, a progressive neurological disorder?二氢嘧啶酶缺乏症,一种进行性神经疾病?
Neuropediatrics. 1997 Apr;28(2):106-10. doi: 10.1055/s-2007-973681.
2
Clinical findings and a therapeutic trial in the first patient with beta-ureidopropionase deficiency.首例β-脲基丙酸酶缺乏症患者的临床发现及治疗试验
Neuropediatrics. 2006 Feb;37(1):20-5. doi: 10.1055/s-2006-923933.
3
beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities.β-脲基丙酸酶缺乏症:一种与神经异常相关的嘧啶降解先天性代谢缺陷病。
Hum Mol Genet. 2004 Nov 15;13(22):2793-801. doi: 10.1093/hmg/ddh303. Epub 2004 Sep 22.
4
Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine.通过尿液气相色谱/质谱分析筛查和诊断β-脲基丙酸酶缺乏症
J Mass Spectrom. 2002 Sep;37(9):954-62. doi: 10.1002/jms.354.
5
Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.戊二酰辅酶A脱氢酶缺乏症的临床病程、早期诊断、治疗及疾病预防
Neuropediatrics. 1996 Jun;27(3):115-23. doi: 10.1055/s-2007-973761.
6
Disorders of purine and pyrimidine metabolism.嘌呤和嘧啶代谢紊乱。
Mol Genet Metab. 2005 Sep-Oct;86(1-2):25-33. doi: 10.1016/j.ymgme.2005.07.027.
7
Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicity.二氢嘧啶酶缺乏症与严重的5-氟尿嘧啶毒性。
Clin Cancer Res. 2003 Oct 1;9(12):4363-7.
8
Dihydropyrimidinase deficiency and congenital microvillous atrophy: coincidence or genetic relation?二氢嘧啶酶缺乏症与先天性微绒毛萎缩:巧合还是遗传关系?
J Inherit Metab Dis. 1997 Sep;20(5):681-8. doi: 10.1023/a:1005374426168.
9
Progressive multifocal leukoencephalopathy in purine nucleoside phosphorylase deficiency.嘌呤核苷磷酸化酶缺乏症中的进行性多灶性白质脑病。
Brain Dev. 2007 Mar;29(2):124-6. doi: 10.1016/j.braindev.2006.07.008. Epub 2006 Sep 1.
10
Dihydropyrimidinase deficiency: structural organization, chromosomal localization, and mutation analysis of the human dihydropyrimidinase gene.二氢嘧啶酶缺乏症:人类二氢嘧啶酶基因的结构组织、染色体定位及突变分析
Am J Hum Genet. 1998 Sep;63(3):717-26. doi: 10.1086/302022.

引用本文的文献

1
Urinary Metabolic Profiling During Epileptogenesis in Rat Model of Lithium-Pilocarpine-Induced Temporal Lobe Epilepsy.锂-匹罗卡品诱导的大鼠颞叶癫痫模型癫痫发生过程中的尿液代谢谱分析
Biomedicines. 2025 Feb 27;13(3):588. doi: 10.3390/biomedicines13030588.
2
The diagnostic odyssey of a patient with dihydropyrimidinase deficiency: a case report and review of the literature.患有嘧啶二羧酸酶缺乏症患者的诊断之旅:病例报告及文献复习。
Cold Spring Harb Mol Case Stud. 2024 Jan 10;9(4). doi: 10.1101/mcs.a006319. Print 2023 Dec.
3
A novel stop-gain mutation in DPYS gene causing Dihidropyrimidinase deficiency, a case report.
一个导致二氢嘧啶酶缺乏症的 DPYS 基因新型移码突变:病例报告。
BMC Med Genet. 2020 Jun 29;21(1):138. doi: 10.1186/s12881-020-01070-6.
4
Confirmation of neurometabolic diagnoses using age-dependent cerebrospinal fluid metabolomic profiles.使用与年龄相关的脑脊液代谢组学特征来确认神经代谢诊断。
J Inherit Metab Dis. 2020 Sep;43(5):1112-1120. doi: 10.1002/jimd.12253. Epub 2020 May 23.
5
Dihydropyrimidinase protects from DNA replication stress caused by cytotoxic metabolites.二氢嘧啶酶可防止细胞毒性代谢物引起的 DNA 复制应激。
Nucleic Acids Res. 2020 Feb 28;48(4):1886-1904. doi: 10.1093/nar/gkz1162.
6
Altered Pre-mRNA Splicing Caused by a Novel Intronic Mutation c.1443+5G>A in the Dihydropyrimidinase (DPYS) Gene.二氢嘧啶酶(DPYS)基因中一个新的内含子突变c.1443+5G>A导致的前体mRNA剪接改变
Int J Mol Sci. 2016 Jan 12;17(1):86. doi: 10.3390/ijms17010086.
7
Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity.一名日本患者中卡培他滨诱导毒性相关的二氢嘧啶酶基因多态性
PLoS One. 2015 Apr 27;10(4):e0124818. doi: 10.1371/journal.pone.0124818. eCollection 2015.
8
Dihydropyrimidinase deficiency: the first feline case of dihydropyrimidinuria with clinical and molecular findings.二氢嘧啶酶缺乏症:首例伴有临床和分子学发现的猫二氢嘧啶尿症病例。
JIMD Rep. 2012;6:21-6. doi: 10.1007/8904_2012_139. Epub 2012 Mar 29.
9
Combined age- and trauma-related proteomic changes in rat neocortex: a basis for brain vulnerability.大鼠新皮质中与年龄和创伤相关的蛋白质组变化的综合分析:大脑易损性的基础。
Neurobiol Aging. 2012 Sep;33(9):1857-73. doi: 10.1016/j.neurobiolaging.2011.09.029. Epub 2011 Nov 16.